Home

Monica Lao šokantan rs medicine Pebish roditelj Povjetarac

A serious issue, will look into it': Supreme Court on claim that Dolo firm  gave freebies to docs | India News,The Indian Express
A serious issue, will look into it': Supreme Court on claim that Dolo firm gave freebies to docs | India News,The Indian Express

Finding Solutions for Drug Shortages: Short and Long-Term Management
Finding Solutions for Drug Shortages: Short and Long-Term Management

Here's why some countries are experiencing medicine shortages – and what  can be done to ensure supply | Gavi, the Vaccine Alliance
Here's why some countries are experiencing medicine shortages – and what can be done to ensure supply | Gavi, the Vaccine Alliance

FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet
FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet

Hyd's Zenara Pharma rolls out generic version of Pfizer's Covid-19 pill at  Rs 5200 per regimen pack | India News - Times of India
Hyd's Zenara Pharma rolls out generic version of Pfizer's Covid-19 pill at Rs 5200 per regimen pack | India News - Times of India

Why Companies are Selling Same Drug in Different Prices? : Pharmaguideline
Why Companies are Selling Same Drug in Different Prices? : Pharmaguideline

Medicine sale by dealers to retailers hit Rs 1.40 trn in Apr-Dec: Mandaviya
Medicine sale by dealers to retailers hit Rs 1.40 trn in Apr-Dec: Mandaviya

Mankind Pharma to launch oral coronavirus drug at Rs 35 per capsule: Report  | Deccan Herald
Mankind Pharma to launch oral coronavirus drug at Rs 35 per capsule: Report | Deccan Herald

FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet
FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet

US Pharmacopeia (USP)
US Pharmacopeia (USP)

NPPA fixes retail prices of 23 drug formulations - The Economic Times
NPPA fixes retail prices of 23 drug formulations - The Economic Times

India's most purchased drugs in the last decade are for cardiac ailments,  diabetes - The Economic Times
India's most purchased drugs in the last decade are for cardiac ailments, diabetes - The Economic Times

Predace 8mg Tablet 10'S - Buy Medicines online at Best Price from  Netmeds.com
Predace 8mg Tablet 10'S - Buy Medicines online at Best Price from Netmeds.com

Dolo pill breaks sales record in pandemic as manufacturer makes a fortune |  Deccan Herald
Dolo pill breaks sales record in pandemic as manufacturer makes a fortune | Deccan Herald

Exclusive I Indians spend Rs 35,820 crore a year on minor ailments, finds  novel survey by pharma body
Exclusive I Indians spend Rs 35,820 crore a year on minor ailments, finds novel survey by pharma body

Micro Labs gets clean chit from pharma body on allegations of spending Rs  1,000 crore on Dolo 650
Micro Labs gets clean chit from pharma body on allegations of spending Rs 1,000 crore on Dolo 650

Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil  Singhvi recommends | Zee Business
Lupin eyes Rs 2,500-crore market with its latest launch in US; what Anil Singhvi recommends | Zee Business

Dolo-650 Tablet Makers Bribed Doctors With Freebies Worth Rs 1,000 Crore To  Prescribe Drug
Dolo-650 Tablet Makers Bribed Doctors With Freebies Worth Rs 1,000 Crore To Prescribe Drug

India's pharma exports rise to Rs 1.83 lakh crore in 2021-22 - Medical Buyer
India's pharma exports rise to Rs 1.83 lakh crore in 2021-22 - Medical Buyer

Dolo breaks sales record; sells over 350 crore pills during COVID-19  pandemic - BusinessToday
Dolo breaks sales record; sells over 350 crore pills during COVID-19 pandemic - BusinessToday

Dolo 650 Maker Micro Labs Rejects Allegations Of Rs 1,000 Crore Worth  Freebies To Doctors
Dolo 650 Maker Micro Labs Rejects Allegations Of Rs 1,000 Crore Worth Freebies To Doctors

A Rs-100 Med Tablet Gives Traders Profit Margin of Over 1000%, Shows Drug  Price Watchdog's Analysis - News18
A Rs-100 Med Tablet Gives Traders Profit Margin of Over 1000%, Shows Drug Price Watchdog's Analysis - News18

Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68  per tablet
Coronavirus India | Cipla to soon launch COVID-19 drug Ciplenza at Rs 68 per tablet

Female Pelvic Medicine and Reconstructive Surgery Subspecialty | ABU
Female Pelvic Medicine and Reconstructive Surgery Subspecialty | ABU

328 Fixed Dose Drugs Bans: Government prohibits 328 fixed dose combinations
328 Fixed Dose Drugs Bans: Government prohibits 328 fixed dose combinations

BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per  pack in India - The Economic Times
BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in India - The Economic Times